Spyre Therapeutics (SYRE) Asset Utilization Ratio (2016 - 2024)
Spyre Therapeutics (SYRE) posted Asset Utilization Ratio of 0.0 for Q1 2024, down 48.59% on a QoQ basis from 0.0 in Q4 2023, and down 91.2% year-over-year from 0.02 in Q2 2023.
Spyre Therapeutics (SYRE) Asset Utilization Ratio (2016 - 2024) Analysis & Trends
Spyre Therapeutics' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q1 2024.
- Quarterly Asset Utilization Ratio fell 91.2% year-over-year to 0.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.0 (down 91.2% YoY) and the FY2023 annual result came in at 0.0, down 83.32% from the prior year.
- Asset Utilization Ratio was 0.0 for Q1 2024 at Spyre Therapeutics, down from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.32 in Q1 2022 and bottomed at 0.0 in Q1 2024.
- A 4-year average of 0.1 and a median of 0.04 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 110.57% — and 2023, when it slumped 95.53%.
- Spyre Therapeutics' Asset Utilization Ratio stood at 0.25 in 2021, then slumped by 88.34% to 0.03 in 2022, then slumped by 88.73% to 0.0 in 2023, then tumbled by 48.59% to 0.0 in 2024.
- Business Quant data shows SYRE's Asset Utilization Ratio at 0.0 in Q1 2024, 0.0 in Q4 2023, and 0.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.32 |
| Dec 31, 2021 | 0.25 |
| Sep 30, 2021 | 0.19 |
| Jun 30, 2021 | 0.09 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.05 |
| Sep 30, 2018 | 0.07 |
| Jun 30, 2018 | 0.10 |
| Mar 31, 2018 | 0.11 |
| Dec 31, 2017 | 0.09 |
| Sep 30, 2017 | 0.08 |
| Jun 30, 2017 | 0.08 |